These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 14021263)

  • 1. [Electrolytic effects of progesterone and its use in the treatment of cardiac edema].
    CHUSTER M
    Arq Bras Cardiol; 1963 Apr; 16():98-112. PubMed ID: 14021263
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrolytes and congestive cardiac failure.
    BHATTACHARYYA MN
    J Indian Med Assoc; 1955 Mar; 24(12):467-70. PubMed ID: 14367849
    [No Abstract]   [Full Text] [Related]  

  • 3. [Differential diagnosis of cardiac insufficiency and differential cardiac therapy].
    REINSTEIN H
    Hippokrates; 1963 Jun; 34():481-8. PubMed ID: 13981491
    [No Abstract]   [Full Text] [Related]  

  • 4. Electrolytes in heart failure.
    MERRILL AJ
    J Med Assoc Ga; 1957 Nov; 46(11):521-2. PubMed ID: 13481546
    [No Abstract]   [Full Text] [Related]  

  • 5. Left ventricular assist device support induces acute changes in myocardial electrolytes in heart failure.
    Monreal G; Gerhardt MA
    ASAIO J; 2007; 53(2):152-8. PubMed ID: 17413553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARdelta activation normalizes cardiac substrate metabolism and reduces right ventricular hypertrophy in congestive heart failure.
    Jucker BM; Doe CP; Schnackenberg CG; Olzinski AR; Maniscalco K; Williams C; Hu TC; Lenhard SC; Costell M; Bernard R; Sarov-Blat L; Steplewski K; Willette RN
    J Cardiovasc Pharmacol; 2007 Jul; 50(1):25-34. PubMed ID: 17666912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of congestive heart failure].
    Aarønaes M; Atar D; Bonarjee V; Gundersen T; Løchen ML; Mo R; Myhre ES; Omland T; Rønnevik PK; Vegsundvåg J; Westheim A
    Tidsskr Nor Laegeforen; 2007 Jan; 127(2):174-7. PubMed ID: 17237864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnesium in congestive heart failure].
    Ohtsuka S; Yamaguchi I
    Clin Calcium; 2005 Feb; 15(2):181-6. PubMed ID: 15692155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute heart failure].
    v Scheidt W
    MMW Fortschr Med; 2004 Apr; 146(15):36, 39-41. PubMed ID: 15373019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone stimulates cardiac muscle protein synthesis via receptor-dependent pathway.
    Goldstein J; Sites CK; Toth MJ
    Fertil Steril; 2004 Aug; 82(2):430-6. PubMed ID: 15302294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiopulmonary interactions in patients with heart failure.
    Monnet X; Teboul JL; Richard C
    Curr Opin Crit Care; 2007 Feb; 13(1):6-11. PubMed ID: 17198043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Edema mechanisms in the patient with heart failure and treatment options.
    Sica DA
    Heart Fail Clin; 2008 Oct; 4(4):511-8. PubMed ID: 18760761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting the long-term effects of cardiac resynchronization therapy on mortality from baseline variables and the early response a report from the CARE-HF (Cardiac Resynchronization in Heart Failure) Trial.
    Cleland J; Freemantle N; Ghio S; Fruhwald F; Shankar A; Marijanowski M; Verboven Y; Tavazzi L
    J Am Coll Cardiol; 2008 Aug; 52(6):438-45. PubMed ID: 18672164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
    Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
    Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Extracorporeal treatment in patients with heart failure: pathophysiology, indications and results].
    Marenzi G; Marana I; Agostoni P
    G Ital Nefrol; 2006; 23 Suppl 36():S46-51. PubMed ID: 17068729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proactive monitoring and management of the chronic heart failure patient. Introduction.
    Fonarow GC
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S1-2. PubMed ID: 16955054
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early warning system for pulmonary fluid status monitoring in terminal heart failure].
    Wedekind H; Möller K
    Dtsch Med Wochenschr; 2007 Mar; 132(11):555-9. PubMed ID: 17342631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracorporeal life support as a treatment for neurogenic pulmonary edema and cardiac failure secondary to intractable intracranial hypertension: a case report and review of the literature.
    Szerlip NJ; Bholat O; McCunn MM; Aarabi B; Scalea TM
    J Trauma; 2009 Sep; 67(3):E69-71. PubMed ID: 19088561
    [No Abstract]   [Full Text] [Related]  

  • 19. Some effects of electrolytic changes in renal disease.
    ALTSCHULE MD
    Med Sci; 1963 Apr; 13():563. PubMed ID: 14012366
    [No Abstract]   [Full Text] [Related]  

  • 20. Current approaches to monitoring and management of heart failure.
    Yancy CW
    Rev Cardiovasc Med; 2006; 7 Suppl 1():S25-32. PubMed ID: 16955057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.